Quantcast
Last updated on April 18, 2014 at 7:29 EDT

Latest BioRestorative Therapies Inc. Stories

2013-08-06 08:32:47

Approval Granted by the Western Institutional Review Board JUPITER, Fla., Aug. 6, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications, today announced that it has received approval from the Western Institutional Review Board ("the Board") to complete a retrospective safety study on selected subjects previously treated by...

2013-08-01 08:35:27

JUPITER, Fla., Aug. 1, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on stem cell-based therapeutics, today announced the issuance of a shareholder letter by Chief Executive Officer, Mark Weinreb, providing an update to shareholders on the Company's progress. The shareholders were advised as follows: Over the past 12 months, BRT's substantial investment in research and development has allowed the Company...

2013-06-24 08:28:12

Strengthens R & D Platform for the Development of Treatments for Metabolic Disorders and Obesity JUPITER, Fla., June 24, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on stem cell-based therapeutics, announced that it has expanded its ThermoStemĀ® Program by collecting 150 samples of human brown adipose tissue (BAT). For the past year, through strategic collaboration and internal BRT efforts, the Company...

2013-06-17 08:28:51

Discusses Company's Unique Business Model and Pipeline of Products JUPITER, Fla., June 17, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX) - Financial personality and Founder of NBT Equities Research, Tobin Smith, recently interviewed BioRestorative Therapies, Inc. (the "Company") CEO, Mark Weinreb, on the firm's hybrid business model and what the firm is currently doing that will help change the biotechnology landscape. BioRestorative is a...

2013-05-29 08:30:18

BRT to Launch "brtx-C Cosmetic" Program JUPITER, Fla., May 29, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications, today announced that it has developed a human cellular-derived extract that, per initial in vitro studies, when applied to skin cells, appears to cause a significant increase in collagen and fibronectin...

2013-05-21 08:28:20

Presentation to be Webcast at 2:30 Eastern Time on May 30, 2013 JUPITER, Fla., May 21, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announced that Mark Weinreb, its President and CEO, will be presenting at the Marcum MicroCap Conference. The conference will be held on Thursday, May 30, 2013 at the Grand Hyatt Hotel, located at...

2013-05-20 08:26:48

Device Plays Integral Role in Delivering Stem Cells for its Proprietary Bulging/Herniated Disc Therapy JUPITER, Fla., May 20, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announces the signing of a consulting agreement with Dexterity, Inc. ("Dexterity"). Dexterity is a product design and bioengineering firm that will provide...

2013-04-23 08:33:41

Initiates New Capital Markets and Digital Media Program JUPITER, Fla., April 23, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTXD), a life sciences company focused on stem cell based cellular therapies for various personal medical applications, today announced the appointment of ProActive Capital Group as its new Capital Markets Advisory and Digital Media Strategies firm. "We are very pleased to have retained the services of ProActive...

2013-04-15 08:28:05

Company to Present Data from its ThermoStem(TM) Brown Fat Stem Cell Program JUPITER, Fla., April 15, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB: BRTX), a life sciences company focused on adult stem cell based cellular therapies for various personal medical applications, announced today that it has been invited to present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria. The conference will take...

2013-04-12 16:23:21

Shares Will Trade on a Split-Adjusted Basis on April 15, 2013 under BRTXD for 20 Day Period JUPITER, Fla., April 12, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on stem cell based cellular therapies for various personal medical applications, announced today that it will implement a one-for-fifty reverse stock split effective at the opening of business on April 15, 2013. Post-split the shares outstanding...